戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 containing fetal bovine serum and antibiotic/antimycotic.
2 ent effects with a few other clinically used antimycotics.
3 isting antifungals demands for new effective antimycotics.
4 level, these compounds also exhibit a strong antimycotic activity in particular against the devastati
5                            We found that the antimycotic agent flucytosine inhibits the expression of
6 a infections and to evaluate the efficacy of antimycotic agents against C. glabrata.
7 plication of a combination of antibiotic and antimycotic agents to ERC contrast media efficiently red
8 rther contribute to developing anti-adhesive antimycotics and combating Candida colonization.
9  following: 56 pharmaceuticals (antibiotics, antimycotics, antivirals, iodinated X-ray contrast media
10   Amphotericin B (AmB) is a clinically vital antimycotic but is limited by its severe toxicity.
11                                          The antimycotic clotrimazole, a potent inhibitor of the inte
12         Bath administration of the imidazole antimycotics, clotrimazole, econazole and miconazole, wh
13 ll walls before and after treatment with the antimycotic drug caspofungin, which alters glucan exposu
14                Previously, we identified the antimycotic drug fluconazole as a potential modulator of
15 rol biosynthesis and primary target of azole antimycotic drugs, are found in pathogenic protists, Try
16 h patients were treated with antibiotics and antimycotics during their hospital stay and be discharge
17 19 and 1:4) were prepared, and the amount of antimycotic entrapped was found to be modulated by the s
18 fective application of amiodarone as a novel antimycotic, particularly in combination with convention
19                     Here, we investigate the antimycotic properties of silver nanoparticles (PP-AgNPs
20                                      Empiric antimycotic prophylaxis initiated at the time of positiv
21 lomatous disease, who require antibiotic and antimycotic prophylaxis to prevent life-threatening bact
22 immunosuppressive therapy and broad-spectrum antimycotic prophylaxis, C. glabrata has emerged as an i
23 rmation to decide on required antibiotic and antimycotic prophylaxis.
24                                          The antimycotic sertaconazole nitrate (STZ) has been shown t
25 le's medium [DMEM]) containing 1% antibiotic/antimycotic solution and 10% fetal bovine serum, and inc
26 valuating GGTase I as a potential target for antimycotic therapy of the related yeast, Candida albica
27   This risk may be reduced with prophylactic antimycotic therapy when culture-positive donor rims are
28  under development for use as broad-spectrum antimycotic therapy.
29 ith 10% fetal bovine serum and 1% antibiotic-antimycotic) was perfused directly through each scaffold
30 ith 10% fetal bovine serum and 1% antibiotic-antimycotic) was perfused directly through each scaffold